Institut Mérieux is contributing its experience in biology to improve medicine and public health across the globe. To fight against infectious diseases and cancer, the Institute imagines and develops new approaches in the fields of diagnostics, immunotherapy, food safety, and nutrition.
Its three bio-industrial companies (bioMérieux, Transgene and Mérieux NutriSciences), working closely with its entities devoted to innovation (such as ABL Inc. and Mérieux Développement), have contributed to major advances in medicine and public health.
Institut Mérieux employs 22,000 people around the world and is present in nearly 45 countries, with 4 billion euros in sales.
Last updated : June 28, 2023